Rezvilutamide for metastatic hormone-sensitive prostate cancer

被引:0
|
作者
Singh, Kirti [1 ]
Mandal, Swarnendu [1 ]
Nayak, Prasant [1 ]
Das, Manoj [1 ]
Tripathy, Sambit [1 ]
机构
[1] All India Inst Med Sci Bhubaneswar, Bhubaneswar 751019, India
来源
LANCET ONCOLOGY | 2022年 / 23卷 / 11期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E490 / E490
页数:1
相关论文
共 50 条
  • [41] How I Treat Metastatic Hormone-Sensitive Prostate Cancer?
    Dabkara, Deepak
    Mondal, Debapriya
    Ghosh, Joydeep
    Biswas, Bivas
    Ganguly, Sandip
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 100 - 107
  • [42] Re: Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2022, 208 (01): : 215 - 216
  • [43] Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
    Shenoy, Niraj
    Kohli, Manish
    INDIAN JOURNAL OF UROLOGY, 2016, 32 (04) : 257 - 261
  • [45] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Murphy, Declan G.
    Zargar, Homayoun
    EUROPEAN UROLOGY, 2016, 69 (03) : 540 - 540
  • [46] Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?
    Kartolo, Adi
    Tannock, Ian F.
    Badillo, Francisco E. Vera
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3573 - +
  • [47] Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer
    de Reijke, Theo
    EUROPEAN UROLOGY, 2016, 69 (01) : 178 - 178
  • [48] Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer
    Wu, Huina
    Sun, Lei
    Feng, Rui
    Zhang, Huiyue
    Tang, Ke
    Wang, Shuo
    Nie, Jing
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [49] Hormone-sensitive prostate cancer
    Ohlmann, Carsten
    UROLOGIE, 2023, 62 (04): : 345 - 346
  • [50] Cytoreductive prostate cryoablation and metronomic cyclophosphamide for metastatic hormone-sensitive prostate cancer
    Li, Yonghong
    Wang, Ning
    Zhao, Diwei
    Wang, Jun
    Jiang, Lijuan
    Wang, Yanjun
    Chen, Dong
    Wu, Zhiming
    Zhou, Fangjian
    Yang, Zhenyu
    FUTURE ONCOLOGY, 2022, 18 (19) : 2373 - 2380